Perrigo (PRGO) Non-Current Assets (2013 - 2026)
Perrigo (PRGO) posted quarterly Non-Current Assets of $5.3 billion for Q1 2026, down 27.06% year-over-year from $7.2 billion in Q1 2025, and down 8.14% quarter-over-quarter from $5.7 billion in Q4 2025.
Perrigo (PRGO) Non-Current Assets (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Non-Current Assets for 14 consecutive years, with $5.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 27.06% year-over-year to $5.3 billion; the TTM figure through Mar 2026 stood at $5.3 billion (down 27.06% YoY), while the FY2025 annual figure was $5.7 billion, down 19.93% from the prior year.
- Non-Current Assets slipped to $5.3 billion in Q1 2026 per PRGO's latest filing, from $5.7 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $8.3 billion in Q4 2022 and bottomed at $5.3 billion in Q1 2026.
- Historically, Non-Current Assets has averaged $7.4 billion across 5 years, with a median of $7.5 billion in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Assets rose 27.27% — and 2026, when it slipped 27.06%.
- Perrigo's Non-Current Assets stood at $8.3 billion in 2022, then slipped by 3.87% to $8.0 billion in 2023, then slipped by 10.16% to $7.2 billion in 2024, then declined by 19.93% to $5.7 billion in 2025, then retreated by 8.14% to $5.3 billion in 2026.
- Business Quant data shows PRGO's Non-Current Assets at $5.3 billion in Q1 2026, $5.7 billion in Q4 2025, and $7.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Perrigo | 1.92 Bn | 1.52 Bn | 313.90 Mn | 5.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 5.16 Bn |
| Mar 28, 2026 | 5.27 Bn |
| Dec 31, 2025 | 5.74 Bn |
| Sep 27, 2025 | 7.20 Bn |
| Jun 28, 2025 | 7.48 Bn |
| Mar 29, 2025 | 7.23 Bn |
| Dec 31, 2024 | 7.17 Bn |
| Sep 28, 2024 | 7.50 Bn |
| Jun 29, 2024 | 7.44 Bn |
| Mar 30, 2024 | 7.83 Bn |
| Dec 31, 2023 | 7.98 Bn |
| Sep 30, 2023 | 7.99 Bn |
| Jul 1, 2023 | 8.19 Bn |
| Apr 1, 2023 | 8.21 Bn |
| Dec 31, 2022 | 8.30 Bn |
| Oct 1, 2022 | 8.09 Bn |
| Jul 2, 2022 | 8.27 Bn |
| Apr 2, 2022 | 6.45 Bn |
| Dec 31, 2021 | 6.57 Bn |
| Oct 2, 2021 | 6.69 Bn |